Search

ROME—Although combination immunochemotherapy —rather than single agent chlorambucil — is widely used among younger patients with chronic lymphocytic leukaemia as a means of improving outcome, the reco

ROME—The idea that clinical evidence can be biased was under scrutiny — at the Rome Conference on Blood Cancer In The Elderly — by Professor Lodovico Balducci, Director of the Senior Adult Oncology Pr

Un-spoken discrimination against older patients with blood cancer may be happening in hospitals because of “quiet rationing” of the expensive drugs such as tyrosine kinase inhibitors, acco

ORLANDO—Awards of $750 000 each were announced at the AACR annual conference in Orlando of Innovative Research Grants, given by the organisation: Stand Up To Cancer to allow some of the best and brigh

ORLANDO—A rare inherited form of skin cancer — basal cell nevus syndrome — has been controlled by an inhibitor of the “hedgehog” molecular pathway in a study reported to the American Assoc

ORLANDO—Evidence that cancer could be controlled more effectively by blocking two molecular pathways simultaneously was reported at the American Association for Cancer Research annual meeting in Orlan

SEATTLE—The world is becoming a healthier place — thanks to improved health systems and effective health policies, according to Professor Martin McKee of the London School of Hygiene and Tropical Medi

A simple cheap drug, tranexamic acid, should be given as early as possible to road traffic accident victims or to any trauma patient at risk of bleeding to death. The latest research from the CRASH-2

ROME—The use of comprehensive psychological assessment of elderly patients with haematological malignancies to look at cognitive and psychological functioning — along with physical factors — was being

ROME—Co-morbidities and cytogenetic markers in older patients with chronic lymphocytic leukaemia can be used as an accurate guide to selecting therapy rather than using age cut-offs, according to Clem

ROME—Testing for the genetic changes predicting prognosis is a key method for choosing the right therapy for your elderly patient with myelodysplastic syndrome according to Francesc Solé, Chief of th

ROME—It is not acceptable to deny patients with acute myeloid leukaemia the most effective treatments on grounds of age alone, according to Norbert Vey, Professor of Haematology at the Universitée de